Literature DB >> 23280575

Isomerization of Asp-Asp motif in model peptides and a monoclonal antibody Fab fragment.

Li Yi1, Nia Beckley, Benson Gikanga, Jennifer Zhang, Y John Wang, Hung-Wei Chih, Vikas K Sharma.   

Abstract

Isomerization of aspartyl (Asp or D) residues is a critical degradation route to consider for stable monoclonal antibody formulations. Among the known hotspot sequences, the DD motif is relatively understudied. To gain mechanistic insights, we used model hexapeptides, YADXFK, YADDXK, and DIDDDM, as surrogates for the hotspots in a Fab protein (YADDFK and DIDDDM), to characterize the rate-pH profile of Asp isomerization. Compared with the YADGFK peptide, isomerization of D3 (the first D in the DD pair) in YADDFK was highly pH dependent. Comparison of rate-pH profiles of YADDFK, YADNFK, and YADHFK revealed a charge effect of the n + 1 residue-isomerization rate is accelerated by the positive side chain and reduced by negative side chain at n + 1 residue. Studies on YADDFK, YADDAK, and YADDGK indicated a mutual impact of D3 and D4 on their respective isomerization rates through charge effect. Comparison of rate-pH profile of DIDDDM sequence in peptide models with that in the complementary determining region of the Fab showed a faster rate in the Fab than in peptides, presumably because of contribution from structural factors in the former.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23280575     DOI: 10.1002/jps.23423

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  In silico selection of therapeutic antibodies for development: viscosity, clearance, and chemical stability.

Authors:  Vikas K Sharma; Thomas W Patapoff; Bruce Kabakoff; Satyan Pai; Eric Hilario; Boyan Zhang; Charlene Li; Oleg Borisov; Robert F Kelley; Ilya Chorny; Joe Z Zhou; Ken A Dill; Trevor E Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

2.  Differences in α-Crystallin isomerization reveal the activity of protein isoaspartyl methyltransferase (PIMT) in the nucleus and cortex of human lenses.

Authors:  Yana A Lyon; Georgette M Sabbah; Ryan R Julian
Journal:  Exp Eye Res       Date:  2018-03-20       Impact factor: 3.467

3.  Structure-based prediction of asparagine and aspartate degradation sites in antibody variable regions.

Authors:  Jasmin F Sydow; Florian Lipsmeier; Vincent Larraillet; Maximiliane Hilger; Bjoern Mautz; Michael Mølhøj; Jan Kuentzer; Stefan Klostermann; Juergen Schoch; Hans R Voelger; Joerg T Regula; Patrick Cramer; Apollon Papadimitriou; Hubert Kettenberger
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

4.  Acetic acid can catalyze succinimide formation from aspartic acid residues by a concerted bond reorganization mechanism: a computational study.

Authors:  Ohgi Takahashi; Ryota Kirikoshi; Noriyoshi Manabe
Journal:  Int J Mol Sci       Date:  2015-01-12       Impact factor: 5.923

5.  Deamidation and isomerization liability analysis of 131 clinical-stage antibodies.

Authors:  Xiaojun Lu; R Paul Nobrega; Heather Lynaugh; Tushar Jain; Kyle Barlow; Todd Boland; Arvind Sivasubramanian; Maximiliano Vásquez; Yingda Xu
Journal:  MAbs       Date:  2018-12-10       Impact factor: 5.857

6.  Improvement of Biophysical Properties and Affinity of a Human Anti-L1CAM Therapeutic Antibody through Antibody Engineering Based on Computational Methods.

Authors:  Heesu Chae; Seulki Cho; Munsik Jeong; Kiyoung Kwon; Dongwook Choi; Jaeyoung Lee; Woosuk Nam; Jisu Hong; Jiwoo Lee; Seonjoo Yoon; Hyojeong Hong
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

7.  Investigation of the interactions of critical scale-up parameters (pH, pO2 and pCO2) on CHO batch performance and critical quality attributes.

Authors:  Matthias Brunner; Jens Fricke; Paul Kroll; Christoph Herwig
Journal:  Bioprocess Biosyst Eng       Date:  2016-10-17       Impact factor: 3.210

8.  Protein engineering to increase the potential of a therapeutic antibody Fab for long-acting delivery to the eye.

Authors:  Devin Tesar; Jacob Luoma; Emily A Wyatt; Catherine Shi; Whitney Shatz; Philip E Hass; Mary Mathieu; Li Yi; Jacob E Corn; Katie F Maass; Kathryn Wang; Michelle Z Dion; Nisana Andersen; Kelly M Loyet; Menno van Lookeren Campagne; Karthikan Rajagopal; Leslie Dickmann; Justin M Scheer; Robert F Kelley
Journal:  MAbs       Date:  2017-08-30       Impact factor: 5.857

Review 9.  In silico prediction of post-translational modifications in therapeutic antibodies.

Authors:  Shabdita Vatsa
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.